2[2]Favier B, Gilles L, Desage M, et al. Analysis of cyclophosphamide in the urine of antineoplastic drugs handlers[J]. Bull Cancer,2003,90(10):905～909.
3[3]Burgaz S, Karahalil B, Bayrak P, et al. Urinary cyclophosphamide excretion and micronuclei frequencies in peripheral lymphocytes and in exfoliated buccal epithelial cells of nurses handling antineoplastics[J]. Mutat Res, 1999,439(1):97～104.
4[4]Connor TH, Anderson RW, Sessink PJ, et al. Surface contamination with antineoplastic agents in six cancer treatment centers in Canada and the United States[J]. Am J Health Syst Pharm, 1999,56(14):1427～1432.
5[5]Yanagawa C. Measures for the disposal of non - regulated alternative medical wastes safe handling of cytotoxic drugs[J].RinshoByori,2000,112(Suppl):120～128.
6[6]Walusiak J, Wagrowska Koski E, Palczynski C. Health effects of occupational exposure to cytostatics in medicinal personnel in the light of compulsory prophylactics: a cross - sectional study[J]. Med Pr,2003,54(3):229～236.
7[7]Valanis B, Vollmer WM, Steele P. Occupational exposure to antineoplastic agents: self - reported miscarriages and stillbirths among nurses and pharmacists[J].J Occup Environ Med, 1999,41(8):632～638.
8[8]Undeger U, Basaran N, Kars A, et al. Assessment of DNA damage in nurses handling antineoplastic drugs by the alkaline COMET assay[ J]. Mutat Res, 1999,439(2):277～285.
9[9]Ziegler E,Mason HJ,Baxter PJ. Occupational exposure to cytotoxic drugs in two UK oncology wards[J]. Occupational and Environmental Medicine,2002,59(9):608～613.
10[10]Pilger A, Kohler I, Stettner H, et al. Long- term monitoring of sister chromatid exchanges and micronucleus frequencies in pharmacy personnel occupationally exposed to cytostatic drugs[J]. Int Arch Occup Environ Health,2000,73(7):442～448.
3Jakab MG,Major J,Tompa A.Follow-up genotoxicological monitoring of nurses handing antineoplastic drugs[J].J Toxical Environ Health A,2001,62(5):307-318.
